November 25, 2025 — Leads & Copy — Organigram Global Inc. has appointed James Yamanaka, previously Global Head of Strategy for British American Tobacco, as its new Chief Executive Officer (CEO), effective around January 15, 2026.
Yamanaka will also join the company’s board of directors upon assuming his role as CEO.
With over 20 years at British American Tobacco (BAT), Yamanaka brings extensive experience in strategy and general management across Europe and Asia, demonstrating a history of creating value-driven strategies, business transformation, and commercial achievements.
During his tenure as Global Head of Strategy at BAT, Yamanaka played a vital role in developing the Group strategy. Earlier, as Area Director for North Asia (Japan and South Korea), he reached record market share in Japan. Before his time in Asia, Yamanaka successfully transformed BAT’s Northern Europe Area by acquiring a nicotine pouch business, which became BAT’s largest growth category.
To ensure a smooth transition, Peter Amirault, the current Board chairman, will serve as executive chair on an interim basis from December 1st until Yamanaka assumes his CEO responsibilities. Geoff Machum, Governance, Nominating and Sustainability Committee chair, will act as the independent lead director during this time.
Amirault expressed enthusiasm about Yamanaka’s appointment, stating that his track record aligns with Organigram’s global aspirations and that his experience will be invaluable for expanding the company’s international presence.
Yamanaka conveyed his excitement about joining Organigram, recognizing its position as Canada’s leading recreational cannabis company by market share and its potential for global leadership. He aims to build upon Organigram’s foundation of high-quality products, trusted brands, and innovation.
Yamanaka holds a BA in Political Science and Economics from UC San Diego, an M.S. in Foreign Service from Georgetown University, and an MBA from London Business School. Based in Toronto, Ontario, he will become CEO after completing necessary procedures, including immigration matters.
This press release contains forward-looking statements which are subject to risks and uncertainties. Actual results may vary. The company disclaims any obligation to update this information, except as required by law.
Forward-looking statements involve risks, uncertainties, and other factors that may cause actual results to differ from those expressed or implied. These factors include consumer demand and those listed in Organigram’s annual information form and other documents filed on SEDAR+ and EDGAR Next.
Readers should avoid placing undue reliance on forward-looking statements. The company believes the assumptions used in preparing these statements are reasonable, but there is no guarantee that the outlined events will occur within the specified timeframes or at all.
The forward-looking information is current as of the release date, and the company does not intend to update or revise it unless legally obligated.
James Yamanaka
Global Head of Strategy for British American Tobacco
Appointed the Company’s new Chief Executive Officer (CEO)
Source: Organigram Global Inc.
